Novel technologies for targeted drug delivery.
Employees: 30
Overview
D-Pharm is a biopharmaceutical company focused on the discovery
Available R&D facilities Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
and development of innovative lipid-based drugs for the treatment
of central nervous system disorders, cancer and autoimmune
diseases.
D-Pharm generates a rich pipeline of safe and effective
pre-clinical and clinical products from its three proprietary
technology engines. D-Pharm's pipeline includes two products in
Phase II for epilepsy and acute stroke, and four in pre-clinical
development for Parkinson's disease, Alzheimer's disease,
psoriasis and neuropathic pain.
D-Pharm's three proprietary technologies are based on its
expertise in membrane biochemistry and lipid medicinal chemistry.
Appropriate analytical and bioanalytical support has also been
developed. By applying proprietary lipid technologies, the
Company creates new chemical entities (NCEs), which have been
demonstrated to be safer and more effective for therapeutic use.
R&D employees: 45
R&D professionals: 25
